Courtagen Spotlight Genetic Tests for Neuromuscular Disorders

Courtagen Life Sciences has launched an expansion of its Spotlight test menu in neurology and endocrinology. The 10 new gene panels increase the company's selection of tests available for epilepsy, developmental delay, endocrinology, and mitochondrial disease. They primarily address neuromuscular disorders, such as congenital myasthenia, hereditary spastic paraplegia, congenital and limb-girdle muscular dystrophy, and myopathies, and one new endocrine disorder test for Bardet Biedl syndrome.